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Emphysema.Abstract Objective: To evaluate whether a simple semi-quantitative method aided by software
enhanced visualization can be reliable enough for the quantiﬁcation of emphysema during the daily
workload.
Patients and methods: Thirty patients with COPD were included. Patients had a standard non
enhanced MDCT study of the chest using a 16 slice machine. The images were evaluated visually
and scored. This scoring was repeated after applying a density mask. Three radiologists evaluated
the images on separate occasions. Repeatability was also tested. The CT emphysema index and the
mean lung attenuation were calculated. The extent of airway disease was not assessed.
Results: Kappa test between the 3 readers revealed slight agreement (k= 0.122, p= 0.001) before
the density mask and substantial agreement (k= 0.75, p< 0.0005) after its application. A high
degree of repeatability was found. The median visual score after density mask application, showed
a stronger correlation to the emphysema index (r= 0.81, p< 0.0005) than before.
Conclusion: We present a simple visual score for quantitation of emphysema, that when combined
with a simple density mask, the inter-rater agreement and repeatability of scoring are markedly
improved. This method appears to be fast and easy to perform.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Chronic obstructive pulmonary disease is a common health
problem that we encounter in everyday patients. The patho-
genesis of the disease is still not fully understood and is prob-
ably a combination of several factors. The factors that were
frequently under study are the degree of airway obstruction
and the extent of emphysema.
The volumetric CT quantiﬁcation of emphysema is not part
of the routine chest CT study in COPD patients until now. The
visual evaluation methods are highly dependent on the radiol-
ogist and his experience level. The quantitative methods, on
the other hand, are time-lengthy and require certain image
674 L.A. Mohsen et al.preparation, e.g. manual extraction of trachea and bronchi.
The aim of our study is to evaluate some of the common
emphysema quantiﬁcation methods in a group of COPD
patients in our community, to determine whether a simple
semi-quantitative method aided by software enhanced visuali-
zation can be reliable enough for the complete evaluation of
emphysema in COPD patients during the daily workload of
a busy radiology department.
2. Patients and methods
Thirty patients (20 males and 10 females; mean age:
60.2 ± 4.4 years old) diagnosed clinically as having COPD
were included in our study. The inclusion criteria were as fol-
lows: (1) ability to have a standard MDCT study of the chest.
(2) CT ﬁndings of normal or emphysematous changes only
were accepted (see #1 in exclusion criteria for explanation).
(3) Complete pulmonary function tests.
Exclusion criteria were as follows: (1) Patients with chest
CT ﬁndings of consolidation, collapse, malignancy, or pleural
abnormalities that might affect the total lung volume. (2)
Patients with incomplete records. (3) Patients with respiratory
failure.
Patients had a standard non enhanced MDCT study of the
chest using a 16 slice GE BrightSpeed machine (GE Healthcare
Medical Systems, Milwaukee, WI). Before the MDCT study,
patients were instructed that they will be required to take
and hold deep inspiration upon request during the study. They
were trained on this manoeuver 5 min before the scanning
starts. The parameters of the CT scan include: 120 kV, auto
tube mAs, slice thickness 5 mm, inter-slice gap 5 mm and res-
olution 512 · 512.
All patients had complete pulmonary function tests and
according to the FEV1 and FEV1/FVC, they were classiﬁed
into the respective GOLD stage (2). None of our patients were
stage IV.
Stage I Mild COPD FEV1/FVC< 0.7 FEV1: P80%
Stage II Moderate COPD FEV1/FVC< 0.7 FEV1: 50–79%
Stage III Severe COPD FEV1/FVC< 0.7 FEV1: 30–49%
Stage IV Very severe COPD FEV1/FVC< 0.7 FEV1: <30%2.1. Image analysis
Emphysema is identiﬁed as areas of hypovascular low attenu-
ation. The images were evaluated visually and scored accord-
ing to the modiﬁed Goddard scoring system which states
that: (1) no signs of emphysema (score 0). (2) Emphysema in
65% (score 0.5). (3) Emphysema in 625% (score 1). (4)
Emphysema in 26–50% (score 2). (5) Emphysema in 51–75%
(score 3). (6) Emphysema in P75% (score 4) (3). This scoring
system was ﬁrst done on the grey scale images. Then this scor-
ing was repeated again after applying a density mask to the
image sequence. The density mask is a density threshold
(950 to 1024 HU) that highlights voxels within this density
range (4). This level was chosen because it correlated best to
the emphysematous changes in the lungs (5). The trachea,
mainstem bronchi, bowel gas and the background of the image
are included in this density range and were not excluded as thiswas a visual score. The local software of the MDCT worksta-
tion (Advantage Windows 4.4 software, GE Healthcare Med-
ical Systems, Milwaukee, WI) was used for the density mask
application. Three independent radiologists evaluated the
images in the same manner and on separate occasions and
their readings were recorded. Repeatability of scoring was
done by one of the authors (L.A.M.) on 2 separate occasions,
1 week apart.
For the quantitative evaluation, again the local software of
the MDCT workstation (Advantage Windows 4.4 software)
was used for the segmentation and CT emphysema index cal-
culation. The CT emphysema index is deﬁned as the propor-
tion of the lung affected by emphysema (1,4). Segmentation
of the lung was done as a prior step to exclude soft tissues
and fat from the ﬁeld of analysis. A threshold of 200 to
1024 HU was applied to the entire image sequence and the
rest of tissues were excluded. Trachea, main stem bronchi,
bowel gas and the background of the images were excluded
manually (6). The image sequence was then revised for correct
segmentation. After image manipulation, the segmented image
sequence is saved and transferred to another computer. Image
J software (National Institutes of Health, USA) was used for
the calculation of the mean lung attenuation (MLA) and the
emphysema index. The images were quantitatively evaluated
considering a density level of 950 HU as the threshold level
for emphysema (5).
The extent of airway disease was not assessed in this study.
2.2. Statistical analysis
Statistical analysis was run on SPSS v16 for Windows (SPSS,
Cary, NC). The tests included the kappa test for inter-rater
reliability of visual analysis. Repeatability was tested by calcu-
lating the intra-class correlation coefﬁcient (ICC) and only
after applying the density mask to the images. Spearman bivar-
iate correlation test was then used to ﬂag the correlations with
the emphysema index. Analysis of Variance (ANOVA) was
used to compare the means of MLA and emphysema index
between the GOLD stages. The median visual score (of the 3
readers) was recorded before and after applying the density
mask. Kruskal–Wallis test was used to compare the visual
score between the GOLD stages. Statistical signiﬁcance was
used at p 6 0.05.3. Results
Thirty patients with clinically diagnosed COPD were included
in this study. The mean age and standard deviation was
60.2 ± 4.4 years old. The study included 20 males and 10
females. Four patients had GOLD stage I, 18 patients had
GOLD stage II while 8 patients had GOLD stage III.
3.1. Inter-rater agreement and repeatability
The modiﬁed Goddard scale used for visual analysis of emphy-
sema varied between the 3 readers as follows (Table 1).
The kappa test run between the 3 readers revealed slight
agreement (k= 0.122, p= 0.001).
After density mask application, the visual analysis scoring
varied as follows (Table 2).
Table 1 The variable scores given to the patients based on the
modiﬁed Goddard score by the 3 independent readers (Before
density mask application).
Reader 1 Reader 2 Reader 3 Number of patients
0 0 0 1
0 0 0.5 6
0 0.5 0 1
2 1 3 1
0 0.5 1 1
0.5 0 0.5 2
0 0 1 2
1 0.5 1 3
2 1 2 3
0.5 0.5 1 3
0.5 1 1 1
3 2 1 2
1 1 0.5 2
3 3 2 2
Total 30
Table 2 The variable scores given to the patients based on the
modiﬁed Goddard score by the 3 independent readers (after
density mask application).
Reader 1 Reader 2 Reader 3 Number of patients
0.5 0.5 0.5 8
0.5 1 0.5 2
0.5 1 1 1
1 0.5 1 1
1 1 1 5
2 2 2 7
2 2 1 1
1 1 2 1
3 2 3 2
3 3 3 2
Total 30
CT quantiﬁcation of emphysema 675The kappa test run between the 3 readers revealed substan-
tial agreement (k= 0.75, p< 0.0005).
A high degree of repeatability was found between the
1-week apart scores, with a single class ICC of 0.93 with a
95% conﬁdence interval of 0.86–0.97. The median difference
of emphysema score was 0 ± 0.5.
3.2. Bivariate correlation
Using the Spearman bivariate correlation test, the median
visual score before density mask application, correlated posi-
tively to the emphysema index (r= 0.62, p= 0.013). After
density mask application, the median visual score showed a
stronger correlation to the emphysema index (r= 0.81,
p< 0.0005; this was at the p= 0.01 level).
3.3. Quantitative measures and GOLD stage
The relation of the visual score, emphysema score, MLA and
emphysema index to the GOLD stage is represented in the next
table (Table 3).4. Discussion
COPD is a very common disease in developing as well as devel-
oped countries due to the different smoking habits as well as
air pollution and occupational exposure. However, it is a het-
erogeneous disease and spirometric results alone failed to
explain the heterogeneity of the disease (7,8).
The marked heterogeneity of the disease led to a problem
with clinical classiﬁcation, where none of the available clinical
staging systems alone allow enough prognostic information
and adequate follow up of the patient care (9). This caused a
growing interest in using CT to give a phenotypic classiﬁcation
for COPD patients, that may aid this clinical characterization
of patients. Fujimoto et al. proposed classifying COPD
patients according to their CT ﬁndings into Phenotype A (no
or minimal emphysema with or without airway disease), Phe-
notype E (emphysema without airway disease) and Phenotype
M (mixed airway and emphysema disease) (1). A similar
approach was also proposed by Han et al., where they sug-
gested that CT could be used to discriminate between patients
with the same spirometric results (10).
With the continuous development in disease management,
researchers have developed new quantiﬁcation methods for
the evaluation of the different chest MDCT ﬁndings in COPD
patients. Airway changes are quantiﬁed by several parameters,
e.g. wall thickness, total airway count and square root of wall
area. Airspace (emphysematous) changes are also quantiﬁed
by some parameters, e.g. emphysema index and semi-quantita-
tive visual scoring system. The airspace and the airway
measures, when co-existent, negatively correlate in COPD
patients (11,12).
Although the airspace damage is irreversible, many
researchers have found that the pre-operative quantitative
CT assessment of emphysema and its distribution predicted a
better post-operative outcome. For example, some authors
suggested that upper lobe emphysema had a better outcome
after lung volume reduction surgery (LVRS) than patients with
predominantly lower lobe emphysema (13–15). Other authors
suggested that pre-operative CT measures of emphysema pre-
dicted a better cardio-pulmonary exercise capacity (16).
A common problem that is encountered with all quantita-
tive analysis is the time factor. All quantitative measures
require some image modiﬁcation, e.g. segmentation, threshold-
ing and manual extraction of some components that would
otherwise affect the calculation process. Also, the overlap
between the disease categories or stages hinders the presence
of a reliable cut-off value that differentiates between the
disease stages. On the other hand, qualitative measures are
highly variable between raters and vary with their experience
levels.
In our study, we present a simple method that may help
reduce the time needed for quantiﬁcation of images and pro-
vide a more reliable and fast semi-quantitative method, hoping
that it may allow the routine quantiﬁcation of emphysema in
routine chest CT studies of COPD patients.
We used the modiﬁed Goddard semi-quantitative score and
combined it with a density mask that is available on most com-
mercial workstations (3). This density mask technique is also
available on many open source image processing software.
This density mask step is a simple preliminary step that pre-
cedes the calculation of emphysema index on most software.
Table 3 Variables for each GOLD stage.
Parameter GOLD I (n= 4) GOLD II (n= 18) GOLD III (n= 8) Signiﬁcance level (ANOVA and K–W tests)
MLA 748 ± 40.8 761.6 ± 41.2 781.3 ± 39.8 0.61
Emphysema index 2.63 ± 2.36 6.48 ± 7.33 7.74 ± 3.53 0.65
Visual score before (range) 0–0.5 0–3 0–2 0.19
Visual score after (range) 0.5 0.5–3 1–3 0.04
676 L.A. Mohsen et al.We wanted to test the inter-rater variability before and after
this density mask application. Inter-rater agreement increased
from slight (k= 0.122) to substantial agreement (k= 0.75).
Without the density mask, the visual score was variably over
or under-estimated (Figs. 1–3). Few authors have resorted to
this density mask method (4,17). In the study by Mu¨ller
et al., this method showed good correlation to the pathological
severity of emphysema (17). Mu¨ller et al. used the density
mask for quantitative assessment of the extent of emphysema
and to the authors’ best knowledge, it was not reported
whether combining this method with a visual score for emphy-
sema would have a good inter-rater agreement than if it was
used on grey-scale images. The modiﬁed Goddard visual score
also proved good correlation to the CT quantitative measures
of emphysema in a previous study (18). We had similar results,
when we compared the median score of the 3 readers before
and after the density mask application to the emphysema
index. We had a stronger correlation between them after its
application than before (r= 0.81, p< 0.0005 vs r= 0.62,
p= 0.013, respectively). Testing the repeatability of the visual
score, we also had a high degree of reliability (single measure
ICC = 0.93). To the authors’ best knowledge, repeatability
was not tested previously for any emphysema visual scoring
system.
We then evaluated the visual score and the quantitative
parameters between the available GOLD stages of COPD
patients, in our study. Although all measures of emphysema
were increasingly getting severe from stage I to stage III, there
was signiﬁcant overlap between the different stages regarding
the visual score, emphysema index and mean lung attenuation.
This is probably due to the low number of cases. The positive
correlation between the quantitative emphysema measures
(emphysema index and MLA) and the clinical stage was
proved in many studies before (19,20).(A)
Fig. 1 A patient with COPD. (A) CT image of the chest reveals nor
score given to this patient was 0. (B) After density mask application,
small, it affected the score.Many authors failed to ﬁnd a direct relation between the
emphysema index and the clinical stage of the patients and
again, they attributed this to the heterogeneity of COPD and
the associated airway disease (18,21–24). Positive relation
was found when patients with Phenotype E were selectively
studied, where this group of patients had lower diffusing
capacity for carbon monoxide (DLCO) and no responsiveness
to bronchodilators (1,25). The distribution of emphysema also
shows different relations to pulmonary function, where
patients with predominant upper lobe emphysema had lower
FEV1, FEV1/FVC and FVC after follow up compared to
patients with predominant lower lobe emphysema (26).
Accordingly, the phenotype of COPD on CT greatly affects
the pulmonary functions.
There are some limitations in our study. First, the low num-
ber of patients is deﬁnitely a drawback and it did not allow us
to study the relation between the density mask aided score and
the pulmonary function tests adequately. However, the rela-
tion of the visual score to the pulmonary functions was not
part of the aim of our study and it is already well known that
the relation would be poor, because we did not select a certain
phenotype of COPD.
Also, the low number of patients was probably the reason
for the absence of correlation between the MLA and the
GOLD stage, a fact that was proven in many studies (19,20).
However, another explanation could be the fact that the used
clinical staging and the inspiratory–expiratory state of the
patient during the MDCT examination differed between these
studies and ours.
Second, the CT scan used in this study is a standard non
contrast enhanced examination. It is well known that the
pre-determined threshold levels vary with the CT acquisition
parameters, e.g. slice thickness, intra-venous contrast as well
as the reconstruction algorithm used (27–30). Although with(B)
mal lung parenchyma. Before density mask application, the visual
the visual score was 0.5. Although the emphysematous region is
(A) (B)
Fig. 2 A patient with COPD. (A) CT image of the chest reveals emphysematous changes in both lungs. Before density mask application,
the visual score given to this patient was 2. (B) After density mask application, the visual score was 1. Some areas that were considered
normal on the ﬁrst image appeared emphysematous on the second image (white arrows) and vice versa with other regions (yellow arrows).
(A) (B)
Fig. 3 A patient with COPD. (A) CT image of the chest reveals normal lung parenchyma. Before density mask application, the visual
score given to this patient was 0. (B) After density mask application, the visual score was 0.5.
CT quantiﬁcation of emphysema 677modern CT scanners, these effects are minimized and the
acquisition parameters, used in this study, are nearly universal
and used in everyday practice, none of our patients had intra-
venous contrast. We did not study whether the score would
differ if patients were given intra-venous contrast or not.
Accordingly, the results of our study will only be applicable
to non-enhanced CT examination.
Finally, we did not include patients with CT ﬁndings of
consolidation, collapse, malignancy or pleural abnormalities.
Although it is not uncommon to see these pathological entities
in COPD patients, they may alter the lung volumetry and
emphysema index. We believe that these changes would not
alter the visual scoring of emphysema which could be another
advantage for the visual scoring. Yet this was not tested in our
study.
5. Conclusion
COPD is a heterogeneous disease with 3 main CT derived phe-
notypes. Within each phenotype, it is essential to have a reli-
able and valid method for assessment of radiological
changes, which in association with other pulmonary function
tests, can aid the follow up of the appropriate treatment given
to patients. Emphysema is one of the COPD phenotypes,either alone (Phenotype E) or mixed with airway disease (Phe-
notype M). Emphysema index was proved in many studies to
predict clinical outcome, mortality and post-operative out-
come after LVRS (11,15,21). In patients with emphysema,
although the emphysema index is an accurate and sensitive
method for quantifying emphysema, yet as any quantitative
measure, it requires time-lengthy image preparation (19).
We present a simple visual score for the quantitation of
emphysema, that when combined with a simple density mask,
the inter-rater agreement and repeatability of the score are
markedly improved. We did not choose any particular pheno-
type of COPD as this was not the aim of our study. This scor-
ing method appears to be fast and easy to perform during the
daily reporting activity in a busy radiology department.Funding
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